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For genetic association studies that involve an ordered categorical phenotype, we usually either 
regroup multiple categories of the phenotype into two categories (“cases” and “controls”) and then 
apply the standard logistic regression (LG), or apply ordered logistic (oLG) or ordered probit 
(oPRB) regression which accounts for the ordinal nature of the phenotype. However, these 
approaches may lose statistical power or may not control type I error rate due to their model 
assumption and/or instable parameter estimation algorithm when the genetic variant is rare or 
sample size is limited. Here to solve this problem, we propose a set-valued (SV) system model, 
which assumes that an underlying continuous phenotype follows a normal distribution, to identify 
genetic variants associated with an ordinal categorical phenotype. We couple this model with a 
set-valued system identification algorithm to identify all the key system parameters. Simulations 
and two real data analyses show that SV and LG accurately controlled the Type I error rate even 
at a significance level of 10−6 but not oLG and oPRB in some cases. LG had significantly smaller 
power than the other three methods due to disregarding of the ordinal nature of the phenotype, and 
SV had similar or greater power than oLG and oPRB. For instance, in a simulation with data 
generated from an additive SV model with odds ratio of 7.4 for a phenotype with three categories, 
a single nucleotide polymorphism with minor allele frequency of 0.75% and sample size of 999 
(333 per category), the power of SV, oLG and LG models were 70%, 40% and <1%, 
respectively, at a significance level of 10−6. Thus, SV should be employed in genetic association 
studies for ordered categorical phenotype.
Keywords
Ordered logistic model; set-valued system identification; multiple thresholds; genetic association 
study; rare variants
Introduction
Genome-wide association studies (GWAS) have successfully identified many genetic 
variants that are associated with complex diseases over the past decades (Sladek et al., 2007; 
Welter et al., 2014). Many phenotypes studied in GWAS are either binary or continuous. 
The logistic regression (LG) and linear regression models are widely used to analyze the 
binary and continuous phenotype while adjusting for the effects of confounding covariates 
such as ancestry, age and sex. In cancer GWAS, considerable portion of phenotypes are 
survival (Innocentiet al., 2012) or relapse (Yang et al., 2012). The Cox proportional hazard 
regression model(Cox, 1972) and the Fine and Gray hazard rate regression(Fine and Gray, 
1999) are the standard methods to analyze survival and relapse outcomes with adjusting for 
some confounding factors such as ancestry scores, treatment arms, clinical risk or prognostic 
factors, respectively.
In cancer pharmacogenetics/pharmacogenomics, we are interested in detecting genetic 
variations influencing drug toxicity or efficacy. The key phenotype referred to as the 
outcome could be multiple ordinal categories such as dosing of drugs, adverse events scored 
on scales using ordinal values (1-5) according to Common Terminology Criteria for Adverse 
Events developed by the US National Cancer Institute (Ingle et al., 2010), and effect of 
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treatment on disease such as tumor response in which the metrics of tumor size is 
categorized as complete response, partial response, stable disease or progressive disease 
(Wheeler et al., 2013). Furthermore, some ordered phenotype may be defined by splitting a 
measured continuous variable such as four categories of underweight, normal weight, 
overweight and obese, based on body index mass, but most of them may be generated due to 
complicated unobservable or unobserved continuous variables such as the expression level 
of RNAs or proteins involved in an unknown biological process or stimulated by external 
environments.
For these ordered phenotypes, researchers often regroup multiple categories into two 
categories of “cases” and “controls” and then apply the standard LG model (Treviño et al., 
2009; Ingle et al., 2010). However, this method may lose substantial power in that re-
categorizing the phenotype does not take the ordinal nature of the phenotype into 
consideration (see Simulation Results section below). The non-parametric method of 
Spearman rank correlation (Yang et al., 2009) or the Jonckheere–Terpstra tests (Han et al., 
2013) which accounts for the ordinal nature of the phenotype can be an attractive method. 
However, these methods cannot adjust for confounding factors. The parametric method of 
ordered/ordinal logistic regression (oLG) model (Png et al., 2011) borrows the basic idea of 
standard LG regression model to avoid these pitfalls. As the most popular model, 
generalized linear models (GLM), logistic approaches adopt link function of logit form, 
which brings many advantages. For example, the first derivative and the second derivative 
of the corresponding log-likelihood function are easy to compute, and the estimated 
parameter can explain the odds ratio directly. Nevertheless, we still think the logistic 
approach sometimes is overused. Above all, fitting the response data with the logit link 
function cannot be justified in many practical applications. The doubt has been confirmed in 
the case of binary outcome for which probit method has better performance than LG method 
under non-asymptotic situations (low MAF and small sample size) (Kang et al., 2014). All 
these two methods will lose statistical power or cannot maintain the type I error rate if the 
marker is rare and sample size is small due to their model assumptions and/or unstable 
parameter estimation algorithm. Another parametric method of the ordered probit regression 
method can also be used but likeoLG, its performance is problematic when the sample size 
is small and the number of categories is large.
As for traditional system identification, the system input and continuous system output are 
usually assumed accessible/known. But in some cases, we can only know which set the 
system output lies in but not the exact continuous output information, which is called set-
valued information (Kang et al., 2014). To model the relationship between system input and 
system output mathematically, a quantization process is adopted to generate the set-valued 
system from the corresponding continuous latent or unknown variable. Set-valued system 
identification (SVSI) was first investigated for sensor systems (Wang, et al., 2003). In 
contrast to the traditional system identification method, SVSI can estimate the model 
parameters by set-valued information rather than precise output information. It is technically 
more challenging, but appears in a wide range of applications such as sensor networks and 
telecommunications (Nair, et al., 2007). Many more motivating examples can be found in 
Wang et al. (2010). Finite impulse response model is a class of typical linear system model 
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and can be used to approximate many actual physical systems. As an important research 
branch of SVSI, the identification of finite impulse response model with set-valued data 
attracts the attention of many researchers and some related results have been obtained 
(Godoy, et al., 2011; Chen, et al., 2012; Bi, et al., 2014).
In this study, we propose a specific set-valued (SV) system model, which can be considered 
as a finite impulse response system with set-valued output. The model considers the 
categorizing process of continuous phenotypes to model the relationship between the 
ordered outcome and possible genetic or non-genetic explanatory factors in GWAS or next-
generation sequencing (NGS) studies. We estimate the parameter of interest by a SVSI 
approach and use a Wald test statistic for testing the null hypothesis of no association 
between genetic variant and ordinal phenotype. We perform extensive simulation studies to 
compare the type I error rate, the power and the computational cost of SV with those of LG, 
oLG and oPRB methods. Finally, we apply the SV method to the data about minimal 
residual disease (MRD) in acute lymphoblastic leukemia (ALL) (Yang et al., 2009) and the 
Genetic Analysis Workshop 17 (GAW17) data.
Materials and Methods
Notations
Assume that we have a cohort of N individuals and that the genetic polymorphism of interest 
is biallelic [e.g., single nucleotide polymorphism (SNP)]. The 2 alleles at a SNP are denoted 
as A and a, where A is the minor allele and together they form three genotypes denoted as 
AA, Aa, and aa. Suppose that observations (si, Xi, Gi), i = 1, 2, ... N are available, where si is 
the ordinal disease outcome of individual i; Xi = [xi1, xi2, ..., xim]T is a vector of m covariates 
that we need to adjust for (e.g., demographic or clinical variables); and Gi = 0, 1, or 2 is the 
numerical coding corresponding to the three genotypes aa, Aa or AA, respectively, for the ith 
individual.
The set-valued (SV) model
We propose a novel set-valued (SV) model in which the phenotype information can be 
regarded as the set-valued observation of a continuous latent variable:
(1)
where Gi and Xi represent the genotype and covariates of subject i, yi is the latent continuous 
variable, f is a deterministic function reflecting the influence of G and X on the latent 
variable, ei is the random noise, IAk(y) is the indicator function of subset Ak and (r+1) is the 
total number of categories of the observed outcome. Observed phenotype si is determined 
based on which set (of sets {Ak, k=0,1,...,r}) the latent variable yi belongs to.
The most common simplified treatment of the set-valued process is to introduce thresholds 
{c1,c2,…,cr} such that [ck, ck+1). To make the representation concise, we assume that c0 = − 
∞, cr+1 = +∞. In this case, SV model is similar to the well-known threshold model. 
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Furthermore, we adopt linear formulation for function f and assume normal distribution for 
the random noise. The model degenerates to the following:
(2)
where ei is the random noise which follows a normal distribution with a mean of 0 and a 
variance of σ2. The null hypothesis of H0: θ = 0 corresponds to no genetic effect of SNP on 
the phenotype. The parameter θ is to be identified only based on observations (si, Xi, Gi), 
i=1,2,...,N to test for the null hypothesis using the expectation-maximization (EM) algorithm 
below.
In equation (2), if c1=0, then the SV model is the usual ordered probit model. If the ei in 
equation (2) follows a logistic distribution in equation (2), then the SV model becomes 
ordered logistic regression (oLG) model (Greene and William, 2003). However, an 
important deviation from the usual ordered probit regression modeling is that here we take a 
novel algorithm SVSI to estimate all the key underlying system parameters θ, γ, and c, 
rather than the iteratively reweighted least squares (IRWLS)algorithm which is usually used 
in the ordered probit regression. Thus, we call the proposed SV model coupled with the new 
SVSI algorithm SV and call the usual ordered probit model with IRWLS oPRB throughout 
the paper to differentiate these two methods due to its better performance below. Without 
calculating the complicated weighting matrix per iteration, the new algorithm can achieve 
efficient results with fast computing time. The detailed discussions and results can be seen in 
results section.
Estimate of θ and test statistic
The system parameters in equation (1) can be estimated by maximizing the likelihood 
function through the EM algorithm. The estimation process is similar to (Chen, et al., 2012). 
Denote (θ, γT, α0)T by an overall parameter Θ,  by an overall input φi. The core 
iteration process is as following:
(3)
where  is the density function and  is 
the cumulative distribution function for a normal distribution with mean 0 and variance σ2 
evaluated at . For more details of MLE, see section 1 in the supplementary 
material.
Suppose the iteration estimator converges to the MLE , the observed Fisher information 
matrix of  (denoted by ) can be obtained according to the following formula (see 
section 1 in the supplementary material for details)
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where L(Θ) is the likelihood function given Θ. Testing for no genetic effect of SNP on the 
phenotype, that is, H0: θ = 0, can be constructed for the SV method from the Wald statistic
(5)
where , the element at the first row and the first column of the inverse Fisher 
information matrix, represents the estimated variance of . Asymptotically, W is distributed 
approximately as a central χ2 distribution with 1 degree of freedom under the null hypothesis 
of no association.
Estimate of threshold C
The estimation of parameters needs the knowledge of threshold vector c=(c1,c2,...,cr).In 
some situations, the thresholds are available. For example, in leukemia, minimal residual 
disease (an assessment of decreasing leukemic burden in response to therapy such as 
chemotherapy for cancer treatment) can be categorized as negative (<0.01%), positive 
(≥0.01% but <1%) and high-positive (≥1%) using two thresholds of 0.01% and 1% (Yang et 
al., 2009). In other cases, the latent variable is unobserved and the thresholds are also 
unknown to us. In the case of binary phenotype, it is very easy to estimate the threshold 
along with other parameters by dealing with the threshold as a parameter (Kang et al., 2014). 
But in case of ordered categorical phenotype, we have to estimate them with some 
techniques. Fortunately, if we presume model parameters as fixed values and threshold as 
variable, the Hessian matrix of likelihood function is positive definite, which means the 
likelihood function has a unique maximum point. Here we adopt a switching operation for 
estimating parameters and thresholds. As for one iteration step, we first estimate model 
parameters (θ, γT, α0)T based on equation (3), and then estimate the threshold c. Through 
extensive simulations, gradient descent method shows good performance on the computation 
time, and is used to estimate the threshold.
(6)
The detailed algorithm implementation of the SVSI method is in Supplementary Section 2 
and the proposed new SV method has been implemented in an R package which is available 
for free download from http://www.stjuderesearch.org/site/depts/biostats/software. The 
simulations adopting SV model and unbiased sampling show that the estimation of 
parameters and thresholds can converge close to the true value within 10 iterations and 
complete the convergence process within 100 iterations (see Table S1 and Figure S1).
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We performed extensive simulation studies to evaluate the performance of the proposed SV 
method against the three competing alternatives including LG for the regrouped binary 
phenotype (recoding as 0 or greater than 0), oLG, and oPRB. We only considered an 
ordered phenotype with three categories (si= 0, 1 and 2) in our simulations.
Genotype and covariates simulations—Given the minor allele frequency(MAF) pA, 
the genotype frequencies p(G=g) were calculated according to Hardy-Weinberg 
equilibrium(HWE) law, i.e., p(G=0)=(1-pA)2, p(G=1)=2pA(1-pA), p(G=2)=(pA)2. Two 
covariates were considered, x1as a binary variable that is 1 with a probability of 0.5 and 0 
otherwise; and x2 as a continuous variable that follows a standard normal distribution. The 
genotypes and 2 covariates for a population of 2,000,000 individuals were independently 
generated from their respective distributions.
Phenotype simulations—The phenotype status was determined from the generated 
genotype and covariates data according to two models below similar to that for the binary 
phenotype simulation method by Kang et al., (2014) and Wu et al., (2011):
1. LG-based simulation method (LGsimu):
We controlled the proportions of individuals with the ordinal disease outcome s = 
2, 1, 0 by α1 and α2 and set it to1:3:6, that is, 10% of individuals have s2, 30% of 
those have s1 and 60% of those have s0, in the case that all three regression 
coefficients for SNP, xi1, and xi2 are 0.
2. SV-based simulation method (SVsimu): First a continuous variable was generated 
from yi=θGi+0.5xi1+0.5xi2+ei, where ei follows a standard normal distribution. 
Given thresholds (c1,c2), the individuals with a value of yi higher than c2 have 
phenotype of 2 and ones with a value of yi lower than c1 have phenotype of 0, the 
remaining have phenotype of 1. We controlled the proportions of individuals with 
the ordinal disease outcome s = 2, 1, 0 and set it to 1:3:6, that is, 10% of individuals 
have s2, 30% of those have s1 and 60% of those have s0, in the case that all three 
regression coefficients for SNP, xi1, and xi2 are 0.
Sample a cohort of N individuals—We select a cohort of N individuals to conduct 
further association analysis based on the following 2 sampling strategies to mimic two 
different designs for retrospective and prospective studies:
1. Randomly sample N/3 individuals per each category (Same): we sample a fixed 
sample size of N/3 individuals from each category in the population of 2,000,000 
individuals to mimic a retrospective design to maximize the power of association 
Bi et al. Page 7













testing. Note that this strategy ensures that the sample size must be a multiple of 3, 
so that for example we may compare results obtained by sampling 999 subjects 
with the Same strategy to those obtained by sampling 1000 subjects with the Rand 
strategy described below.
2. Randomly sample N individuals (Rand): we randomly choose N individuals from 
the population of 2,000,000 individuals simulated above to mimic a prospective 
design.
Once the data is generated, for LG, we used glm function in R and fit the glm on the 
regrouped binary phenotype (new si= 0 if the original si= 0 or new si= 1 if the original si = 1 
or 2), genotype and two covariates. For oLG and oPRB, we used polr function in MASS R 
package and fit polr on the original three-categorical phenotype, genotype and two 
covariates. Then the Wald test statistic was used for inference for all these three methods to 
be consistent with the SV method.
Type I error rate simulations
Eight values for MAFs of SNPs were considered: 0.0025, 0.0075, 0.01, 0.05, 0.1, 0.2, 0.3, 
0.4 and 0.5. The ordered phenotype was determined from the generated genotype and 
covariate data by using the two models mentioned above, with θ= 0. To estimate the type I 
error rate of the SV method, 10,000,000 replicated datasets were simulated for each study, 
with a small sample size of 1000 (2500) and a large sample size of 2000 (5000) for the 
Rand sampling method for variants with MAF≥0.0075 (MAF=0.0025) and the 
corresponding numbers of 999 (2499) and 1998 (5001) for the Same sampling method, 
respectively. We considered larger significance levels α = 0.05 or 0.01 and stringent 
genome-wide levels α = 10−5 or 10−6 under the null hypothesis of H0: θ = 0.
Power simulations
Three genetic disease models were considered: additive, dominant, and recessive with their 
respective genotype coding G (0, 1, 2), (0, 1, 1) and (0, 0, 1) when we simulated the 
phenotype. The ordered phenotype was determined from the generated genotype and 
covariate data according to the simulation methods given above, with θ varying from 0.3 to 
2 at an increment of 0.1. Datasets were generated 10,000 times for each configuration. The 
three methods used for the type I error simulations were applied to each data-set, and power 
was estimated as the proportions of p-values less than α = 10−6.
To mimic a phase II clinical trial, a small sample size of 150 was also used for common 
variants with MAFs of 0.2 and 0.05 to estimate the power of SV at a significance level of 
1×10−4.
Results
Type I error rate
Table 1 shows empirical type I error rates estimated for four methods. Regardless of 
significance levels, SV correctly maintained type I error control at the given levels for both 
common and rare variants. LG was conservative for stringent genome-wide levels if SNPs 
Bi et al. Page 8













were rare because of large variance of parameter estimate (Table 2) (Kang et al., 2014). 
oLG and oPRB correctly controlled type I error rate at larger significance levels but did not 
control type I error rate at stringent genome-wide levels for rare variants when sample size 
was small because of instability of oLG and oPRB when there are some empty or small 
cells. Since oPRB cannot control type I error rate at α = 10−6 for rare SNP with MAF 
0.0075 and the power of SV is almost identical to that of oPRB in most cases, the power of 
oPRB was omitted and was not included in the section below.
Power of the SV method
Figures 1–2 show the power of the three methods as a function of effect size (θ) for an 
additive disease model. As expected, the power of SV and oLG increased with the increase 
in effect size regardless of distributions of noise, the genetic disease model and sampling 
methods. The power of three methods was generally higher for Same sampling method than 
that for Rand sampling method for the same parameter setup. This suggests that for a 
retrospective design, sampling all individuals with more extreme phenotype is preferred for 
assessing genetic effect. In some settings, both SV and oLG based on ranked sets performed 
better than LG based on the regrouped sets. The power difference between them could be 
more than 50% at a significance level of 10−6 depending on the scale of the sample size. As 
expected, for a SNP with MAF of 0.05, given a sample size of 1000 with Rand and 999 
with Same, the power of LG for the regrouped binary outcome first increased to 100%, then 
decreased with increase in effect size (Figure 2A-2B). The drop of the power of LG method 
for the very large effect size given a small fixed sample size and a SNP with small MAF is 
due to the high probability of absence of individuals with phenotype 0 and carrying minor 
alleles (see population 3×3 tables in Supplementary matrix 1 for θ = 1 and 2, respectively), 
which leads to a very large estimated standard error of  by LG. For example, given N = 
999, for θ = 1, 0 out of 1000 simulated datasets had absence of individuals with phenotype 0 
and carrying minor alleles so that the mean and the standard deviation of  were 2.024 and 
0.258 which leaded to a standardized effect size of . However, for θ θ = 2, 58 out 
of 1000 simulated datasets had absence of individuals with phenotype 0 and carrying minor 
alleles so that the mean and the standard deviation of  were 4.50 and 3.288 which leaded to 
a standardized effect size of  which is much smaller than that for θ = 1. Below we 
will focus on power comparison between SV and oLG. The power gain for the new SV 
method was noticeable in detecting rare variants especially when the individuals was 
sampled using Same sampling method from the population generated using SVsimu 
(Figures 1-3).
For a common SNP with an MAF of 0.2 or 0.05, the power of SV appeared to be similar to 
or higher than that of oLG depending on the scale of sample size, regardless of the genetic 
disease models, sampling methods and distributions of noise (Figures 1-2, and 4). 
Surprisingly, with a small sample size of N=150, for a SNP with a MAF of 0.2 and θ = 0.7, 
the power difference between SV and oLG was 8% (Figure 4B and 4D). But for a SNP with 
a MAF of 0.05 and θ = 1.5, the power difference between SV and oLG was 15% (Figure 4B 
and 4D).
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For a rare SNP with an MAF of 0.0075 or 0.0025, if the noise follows a logistic distribution, 
with Rand sampling method, the power of oLG was almost identical to or slightly higher 
than that of SV, regardless of genetic disease models (Figure 1A-1C). However, 
interestingly, with Same sampling method, the power of SV was slightly or much higher 
than that of oLG, regardless of genetic disease models (Figure 1B-1D). For example, for a 
SNP with MAF of 0.0075, θ = 2 (equivalent to OR=eθ=7.4), and N=999, the power 
difference was 12% between oLG and SV (Figure 1B). Similarly, for a SNP with MAF of 
0.0025, θ = 1.8 (equivalent to OR=eθ=6), and N=5001, the power difference was 10% 
between oLG and SV (Figure 1D). If the noise follows a normal distribution, regardless of 
sampling methods, the power of SV was generally higher than that of oLG (Figure 2). The 
power difference between oLG and SV became larger at larger effect size and smaller 
sample sizes. For example, for a SNP with MAF of 0.0075, θ = 2, and N=999, the power 
difference was 24%between oLG and SV (Figure 2A). Similarly, for a SNP with MAF of 
0.0025, θ = 2, and N=1000, the power difference was 17% between oLG and SV (Figure 
3B). These results indicate that for rare genetic variant association studies, we strongly 
recommend SV be employed instead of LG and oLG if the phenotype was defined from a 
continuous normal distribution.
Figure 3 displays the power of the SV and oLG methods as a function of sample size for the 
additive disease model. As expected, the power of two methods increased with an increase 
in sample size. For a common SNP with an MAF of 0.2 or 0.05 and an effect size of 0.4 or 
0.8, respectively, the power of SV was almost identical to that of oLG, regardless of the 
distributions of noise, sample size, disease models and sampling methods (Figure 3). For a 
rare SNP with a MAF of 0.0075 or 0.0025 and an effect size of 2 or 2.4, if the noise follows 
a logistic distribution and a Rand sampling method is used, the power of SV appeared to be 
similar to that of oLG, regardless of the disease models (Figure 3A) but the power of SV 
was much larger than that of oLG for a Same sampling method (Figure 3B). The power 
difference became larger with moderate sample sizes. If the noise follows a normal 
distribution, regardless of sampling method, the power of SV was much greater than that of 
oLG but depending on the sample size (Figure 3C-3D).
Variance of the genetic association parameter estimate
Table 2 and Supplementary Table 2S gives the mean of , mean of estimated standard errors 
of , and standard deviations of  across simulation repetitions for the LG, SV and oLG 
methods based on 1,000 simulation repetitions. Data were generated using the same 
parameter setup as given in Table 1 and Figures 1–4.
The mean of estimated standard error of  appeared to be close to its standard deviation for 
the SV method in all simulation setups but not for LG, oLG and oPRB (Table 2 and 
Supplementary Table 2S). Interestingly, when SNP is rare (pA=0.0075) and association 
parameter is large (θ=2), the means of estimated standard errors of  for the oLG and LG 
method were much larger than their standard deviations, especially when the sample size 
was small, which leads to their significant power loss compared with RV and oPRB. This is 
not surprising since in this setting, there is a high probability of absence of individuals with 
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phenotype 0 and carrying minor alleles, which leads to a very large estimated standard error 
of .
We also calculated the ratio of the mean of  over the mean of estimated standard error of , 
i.e, , and the ratio of the mean of  to the standard deviation of , i.e, , which were 
used to mimic the standardized effect sizes to make the estimates a comparable scale and 
was used to compare different models (Table 2 and supplementary Table 2S). Under the null 
hypothesis, no matter what the phenotype simulation model, sampling method, MAF and 
sample size, both standardized effect sizes with SV were very close and both were close 0 
which showed that SV could control type I error rate but not for oLG. Under some extreme 
situations such as small sample size and rare SNP,  was higher than  for oLG but 
both would be close to 0 as sample size increased. Under the alternative hypothesis, in most 
cases SV had the “standardized effect sizes” similar to oLG both were much larger than LG 
which further demonstrates that SV had the power similar to oLG both had larger power 
than LG in most cases. Under some extreme situations, rare SNP, small sample size or large 
effect size, SV had higher “standardized effect sizes” than oLG, which clearly demonstrated 
the power gain of SV compared with LG and oLG for these settings. All these simulation 
results obviously demonstrate that SV can give more efficient, more robust and much less 
variable  than oLG. In particular, it dominates others under small sample sizes and rare 
variants.
We also recorded the computing time for each of the four methods above as implemented in 
R and Matlab for the simulated data. In Matlab, SV was typically about twice as fast as 
oPRB and oLG but was similar to LG. In R, SV, oPRB, and oLG had similar run times 
with SV tending to be slightly slower than oLG but all was slower than LG (Supplementary 
materials section 3 and Table 3S). These are consistent with the results reported by Bi et al. 
(2014).
Application to the top 25 SNPs of MRD in ALL
ALL is the most common type of cancer in children and the cure rate is more than 80% but 
there exists considerable inter-individual variability in therapy response (Yang et al., 2009). 
Genetic variants of SNPs in the interleukin 15 (IL15) gene and other SNPs associated with 
risk of MRD at the end of induction therapy have been reported recently (Yang et al., 2009). 
We analyzed the top 25 SNPs identified by Spearman rank correlation test in childhood 
ALL in two independent populations: 318 patients in St Jude Total Therapy protocols XIIIB 
and XV (Pui et al., 2004, 2009), and 169 patients in Children's Oncology Group (COG) trial 
P9906 (Borowitz et al., 2003). For St Jude patients, MRD status was categorized as negative 
(<0.01%), positive (≥0.01% but <1%), and highpositive (≥1%). For COG patients, MRD 
status was similarly categorized as: negative (≤0.01%), positive (>0.01%, but ≤1%), and 
high-positive (>1%).
Table 3 shows association results for the top 25 SNPs in both and combined cohort of St 
Jude and COG. At a significance level of 0.05/25 = 0.002, in the combined cohorts, 24 SNPs 
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were found statistically significant by LG, oLG and oPRB but 23 of them were detected by 
SV; for St. Jude cohorts, LG, oLG, oPRB and SV found 10, 9, 9, and 8 SNPs statistically 
significant, respectively, where 5 were detected by all four methods; for COG cohorts, LG, 
oLG, oPRB and SV found 8, 8, 7 and 8 SNPs statistically significant, respectively, where 6 
were detected by all four methods. There were only one SNP (SNP_A-1794325) detected by 
all our methods in both SJ and COG cohorts. Overall, the p-values for all four methods were 
comparable. Based on these results it seems that all four methods perform similarly. 
However, we know that the distribution of the continuous MRD measure at the end of 
induction therapy was right-skewed and definitely not following a normal distribution 
especially for ALL (Moppett et al., 2003). More importantly, we do not know what are the 
true SNPs associated with MRD in ALL.
Application to the Mini-Exome Data of Genetic Analysis Workshop 17
To further evaluate the performance of the proposed SV method, we analyzed data from the 
Genetic Analysis Workshop 17 (GAW17) which contained “mini-exome” sequence 
genotype data of 24,487 SNPs in 3,205 genomic regions of 697 unrelated individuals 
provided by the 1000 Genome Project [27]. Three quantitative phenotypes (Q1, Q2, and Q4) 
were simulated from the normal distribution. Q1 was influenced not only by genetic variant, 
but also environmental variables, and gene-environmental interactions. Q2 was only 
influenced by genetic variants not environmental variables. Q4 was influenced only by the 
environments and not genetic variants. Here we only analyzed Q2 since there were no 
environments and gene-environments interactions associated with Q2. Q2 was influenced by 
72 SNPs in 13 genes. Furthermore, 200 replicate datasets were generated for each 
phenotype, using one fixed genotype data. To apply our methods to GAW17 data, we 
classified Q2 to the ordered categorical phenotype using Φ−1(0.9) and Φ−1(0.6) as two 
thresholds and then analyzed them by mimicking we do not know Q2 which is the same as 
our SV model. First, quality control analysis was performed on the SNPs and SNPs with 
MAFs less than 0.0086 or HWE test p-values less than 0.00001 were excluded. There were 
8387 SNPs remaining in the association analysis of Q2. The reclassified ordered categorical 
phenotype for the 1st, 10th, 100th and 200th replicate data was used as our outcomes 
(supplementary Table S3 for frequency table and Figure S2 for the histograms) and included 
age, gender, and smoking status as covariates in all four methods above.
Table 4 shows the association analyses results for Q2. At a significance level of 0.00001, for 
the 1st replicate data, there was no SNP found statistically significant by using SV and LG 
but there were 112 no-causal SNPs found statistically significant by using oLG and oPRB, 
which was similar to the 10th replicate data. For the 200th replicate data, at a level of 
0.00001, no SNP was found statistically significant by any of the four methods. For the 
100th replicate data, SV and LG only found one true causal SNP but did not detect no-causal 
SNPs. oLG and oPRB also found the same true causal SNP but simultaneously found 99 
no-causal SNPs whose p-values were 0. At a significance level of 0.0005, SV found more 
true causal SNPs than and similar no-causal SNPs to LG. SV found similar true causal SNPs 
to but much less no-causal SNPs than oPRB and oLG. GAW17 data analyses showed that 
SV had similar or higher power than oLG and oPRB but the latter cannot maintain the type 
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I error rate. They were consistent with and further supported our extensive simulation results 
above.
Discussion
With the availability of data from whole-genome sequencing and whole-exome sequencing 
studies in which small or moderate sample sizes are used due to the high cost of sequencing 
technology (Lanktree et al., 2010; Emond et al., 2012) and/or the rare diseases in cancer 
pharmacogenomics studies such as pediatric cancers of retinoblastoma and Ewing's (Gurney 
et al., 1995; Wheeler et al., 2013), there is an increasing demand for the development of 
powerful and robust association testing procedures for identifying genetic variations 
associated with an ordered multiple responses phenotype of interest. In this study, we 
propose a new SV system that models the relationship between an ordered phenotype and 
genetic variants and introduce an SVSI approach to testing the genotype-ordered categorical 
phenotype association. To be more detailed, the simplified SV model assumed the system 
noise following a normal distribution. The normal distribution assumption is considered 
reasonable because it is in accordance with the classical central limit theory. And after a 
simple transformation, we find the logistic approach is also a specified form of SV model, 
and the diversity is that the system noise is slightly different from the normal distribution. 
The diversity is so subtle that the corresponding results show tiny difference under 
asymptotic situations, i.e. common MAF and/or large sample size. Under non asymptotic 
situations, i.e. low MAF and/or small sample size, it is inevitable to suffer power loss for 
every statistical method. And the degree of power loss depends largely on the underlying 
assumptions. Through simulations, we found that both LG and oLG methods suffered 
obvious power loss because of high variance of estimated parameter and that oPRB and oLG 
could not control type I error at a stringent significance level. While the SV method 
sustained a better performance in these situations due to the normal distribution of the noise 
term compared to the logistic distribution with heavier tails as well as the updated 
computationally efficient and robust EM algorithm.
The statistical methods based on model are the most effective when the model is in 
accordance with actual data. Invalid model assumption will bias the results more or less. 
Hence, we think it is very important to compare two methods under their own model 
assumptions. Simulations and real data applications show that the proposed SV method has 
a robust performance for testing association between ordered phenotypes and genetic 
variations regardless of the logistic or normal distributions of noise and genetic disease 
models, and that generally outperforms the commonly used LG model, and oLG especially 
when the SNP is rare and when the sample size is limited. Thus, we recommend the use of 
the SV approach instead of the LG or oLG model, to identify genetic variants in genetic 
association studies for ordered phenotypes. Although not reported here, simulation studies 
showed similar results for the dominant and recessive disease models and for a common 
SNP with MAFs such as 0.1, 0.3, 0.4 or 0.5.
When we estimate the parameters using the system identification method, we suppose that 
the variance of noise is known as 1 because we are interested in testing genotypephenotype 
associations not estimating the effect size of association. In real data analysis, the true 
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variance of noise is usually unknown and also may not be equal to 1 which will definitely 
affect the power of the LG, oLG and SV. By simulations, not surprisingly, as the true 
variance is bigger (smaller) than 1, the power of all three methods will decrease (increase). 
However, as expected, the power of the SV method is still identical to or higher than that of 
oLG and both are much higher than that of LG (data not shown). If the distribution of 
underlying noise is neither normal distribution nor logistic distribution, for example, t-
distribution, simulation results show the same conclusion. Thus, conclusions about the 
power gain of the SV compared to LG and oLG is robust to the logistic, normal and t 
distribution of the underlying noise. In addition, if we are interested in estimating the 
association effect size of SNP on the phenotype, the noise variance parameter can also be 
estimated along with other parameters using generalized expectation maximization 
algorithm (Godoy et al., 2011). We have implemented the proposed new SV method in an R 
package which is available for free download from http://www.stjuderesearch.org/site/depts/
biostats/software. The method can be easily applied to candidate gene association analysis, 
GWAS or NGS studies with hundreds or thousands of individuals for ordered categorical 
phenotypes.
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Figure 1. Power of SV method for the additive model using LGsimu simulation method
Panels A and B show sample sizes of N=1000 (999) and 2500 (2499) for common and rare 
variants, respectively. Panels C and D show sample sizes of N=2000 (1998) and 5000 (5001) 
for common and rare variants, respectively. The solid, dotted and dash lines correspond to 
the SV, LG and oLG methods, respectively. The numbers of 1-4 correspond to the tested 
SNPs with MAFs of 0.2, 0.05, 0.0075 and 0.0025, respectively. The significance level of the 
test was 1×10−6.
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Figure 2. Power of SV method for the additive model using SVsimu simulation method
Panels A and B show sample sizes of N=1000 (999) and 2500 (2499) for common and rare 
variants, respectively. Panels C and D show sample sizes of N=2000 (1998) and 5000 (5001) 
for common and rare variants, respectively. The solid, dotted and dash lines correspond to 
the SV, LG and oLG methods, respectively. The numbers of 1-4 correspond to the tested 
SNPs with MAFs of 0.2, 0.05, 0.0075 and 0.0025, respectively. The significance level of the 
test was 1×10−6.
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Figure 3. Power of SV method as a function of sample size
The left and right panels show LGsimu and SVsimu, respectively. The x-axis is the sample 
size divided by 100. The solid and dash lines correspond to the SV and oLG methods, 
respectively. The numbers of 1-4 correspond to the tested SNPs with MAFs of 0.2, 0.05, 
0.0075 and 0.0025, respectively. The significance level of the test was 1×10−6. θ values 
were 0.4, 0.8, 2 and 2.4 for SNPs with MAFs of 0.2, 0.05, 0.0075 and 0.0025, respectively.
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Figure 4. Power of SV method for detecting common variants using 150 individuals under the 
additive model
The left and right panels show phenotype simulation methods of LGsimu and SVsimu, 
respectively. The solid and dash lines correspond to the SV and oLG methods, respectively. 
The numbers of 1-2 correspond to the tested SNPs with MAFs of 0.2 and 0.05, respectively. 
The significance level of the test was 1×10−4. The legends of panels BD are the same as that 
of panel A.
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